Patients News | pharmaphorum

News

Lilly launches discounted high-strength Zepbound vials in US

Eli Lilly's drive to provide as many treatment options as possible for its obesity drug Zepbound has continued with the launch of new high-dose vials.

News

AI tool detects brain lesions linked to epilepsy

Researchers developed an artificial intelligence-powered tool that was able to detect two-thirds of epilepsy brain lesions missed by radiologists.

News

Kennedy delays first vaccine expert meeting under his watch

Less than a week into the tenure of Robert F Kennedy Jr as HHS secretary, there are more signals that US immunisation is going to be shaken up.

News

NICE changes its mind on BMS' lymphoma cell therapy

Around 600 people with various types of B-cell lymphoma will be eligible for treatment with BMS' CAR-T therapy Breyanzi under new NICE guidance.

News

SMA treatment with Evrysdi 'could start prenatally'

Should treatment of neurodegenerative disorder SMA with Roche's Evrysdi start even before birth? One case study suggests so.

News

UCB's non-cannabis drug for severe epilepsy gets NHS okay

Around 1,400 patients with Lennox-Gastaut Syndrome will be eligible for NHS treatment with UCB's Fintepla after a NICE recommendation.

Lilly launches discounted high-strength Zepbound vials in US

AI tool detects brain lesions linked to epilepsy

Kennedy delays first vaccine expert meeting under his watch

NICE changes its mind on BMS' lymphoma cell therapy

SMA treatment with Evrysdi 'could start prenatally'

UCB's non-cannabis drug for severe epilepsy gets NHS okay

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks